Preview

Vestnik of North-Eastern Federal University. Medical Sciences

Advanced search

Pelvic inflammatory disease: clinical aspects and influence on women’s reproductive health

https://doi.org/10.25587/2587-5590-2026-1-5-15

Abstract

Pelvic inflammatory disease (PID) remains a leading cause of impaired reproductive health in women. This study aimed to identify clinical and anamnestic characteristics associated with PID and to evaluate subsequent reproductive outcomes following inpatient management. We retrospectively analyzed clinical and anamnestic data from 66 women diagnosed with PID and assessed fertility-related outcomes in those who completed inpatient treatment. Early menarche and sexual debut before age 16 were significantly associated with an increased risk of complicated PID (p=0,033), likely attributable to alterations in vaginal microbiota secondary to high-risk sexual behavior. The clinical presentation of PID was notably non-specific: 90.9 % of the patients reported abdominal pain, and 90.9 % exhibited elevated C-reactive protein levels. Notably, 77.3 % of the cases were initially misdiagnosed as acute appendicitis, underscoring the persistent diagnostic challenges in differentiating PID from other acute abdominal conditions. Etiologically, all identified pathogens in this cohort belonged exclusively to opportunistic microflora; no sexually transmitted infection (STI) agents, including Chlamydia trachomatis or Neisseria gonorrhoeae, were detected. Polymicrobial (mixed) infections were present in 29.5 % of the cases and were significantly associated with tubo-ovarian abscess formation and more severe pelvic adhesions (p=0.024). Uncomplicated PID predominated (86.4 % of the cases), whereas the presence of a tubo-ovarian abscess correlated strongly with extensive adnexal adhesions. Among the patients with uncomplicated disease who received timely, fertility-sparing laparoscopic intervention, pregnancy occurred in 16.7 % and live birth was achieved in 12.1 %. The annual fertility rate in this subgroup was 88.9 live births per 1,000 women, which is comparable to the agematched national population rate reported by Rosstat (Russian Federal State Statistics Service). These findings demonstrate that appropriate broad-spectrum antimicrobial therapy combined with minimally invasive, organpreserving surgical management can effectively preserve fertility even after an episode of PID.

About the Authors

A. M. Bogdanova
Ural State Medical University, Ministry of Healthcare of the Russian Federation; Central City Hospital No. 7
Russian Federation

Bogdanova Anna Mikhailovna, Cand. Sci. (Medicine), Assistant lecturer, Department of Human Anatomy, Topographical Anatomy and Operative Surgery; Obstetrician Gynecologist

Yekaterinburg



O. E. Knysh
Ural State Medical University, Ministry of Healthcare of the Russian Federation
Russian Federation

Knysh Oleg Evgenievich, Student, Institute of Clinical Medicine

Yekaterinburg



E. V. Knysh
Kurgan Regional Clinical Hospital
Russian Federation

Knysh Evgeny Vladimirovich, Head of the Gynecology Department

Kurgan



A. V. Urakov
Central City Hospital No. 7
Russian Federation

Urakov Andrey Vladimirovich, Head of Gynecology Department No. 1

Yekaterinburg



E. L. Mamin
Central City Hospital No. 7
Russian Federation

Mamin Eduard Leonidovich, Deputy Chief Physician for Obstetrics and Gynecology

Yekaterinburg



References

1. Selikhova M.S., Smolyaninov A.A. State-of-the-art therapy for salpingo-oophoritis from the perspective of novel clinical guidelines. RMJ: Mother and Child. 2022;5(1):35–40 (in Russian). https://doi.org/10.32364/2618-8430-2022-5-1-35-40

2. Brun J.L., Graesslin O., Fauconnier A., et al. Pelvic inflammatory diseases: updated French guidelines. Journal of Gynecology Obstetrics and Human Reproduction. 2020;49(5):101714. https://doi.org/10.1016/j.jogoh.2020.101714.

3. Yusuf H., Trent M. Management of pelvic inflammatory disease in clinical practice. Therapeutics and Clinical Risk Management. 2023;19:183–192. https://doi.org/10.2147/TCRM.S352121.

4. Adamyan L.V., Sivitskaya E.V., Khlybova S.V., et.al. Modern problems of diagnosis and treatment of inflammatory diseases of pelvic organs in adolescent girls. Russian Journal of Human Reproduction. 2022;28(1):75–80 (in Russian). https://doi.org/10.17116/repro20222801175.

5. Workowski K.A., Bachmann L.H., Chan P.A., et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recommendations and Reports. 2021;70(4):1–187. https://doi.org/10.15585/mmwr.rr7004a1.

6. Federal State Statistics Service (Rosstat). Age-specific fertility rates, 2022. Moscow: Rosstat; 2022. Available at: https://www.fedstat.ru/opendata/7708234640-fiveanineaeightatwoaseven (accessed: 07 May 2025) (in Russian).

7. Minaev S.V., Timofeev S.I., Grigorova A.N., et.al. Specific features of the adhesion process of the abdominal cavity in children with different degrees of connective tissue dysplasia. Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care. 2020;10(4):381–389 (in Russian). https://doi.org/10.17816/psaic705.

8. American Fertility Society. The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, Müllerian anomalies and intrauterine adhesions. Fertility and Sterility. 1988;49(6):944–955. https://doi.org/10.1016/S0015-0282(16)59942-7.

9. Ibitoye M., Copen C.E., Wall K.M., et.al. Sexual and reproductive health covariates of early menarche among adolescent girls. The Journal of Adolescence. 2024;96(4):789–802. https://doi.org/10.1002/jad.12302.

10. Sordia-Hernández L.H., Serrano Castro L.G., Sordia-Piñeyro M.O., et.al. Comparative study of clinical features of patients with tubo-ovarian abscess and patients with severe pelvic inflammatory disease. International Journal of Gynecology and Obstetrics. 2016;132(1):17–19. https://doi.org/10.1016/j.ijgo.2015.06.050.

11. Bridwell R.E., Koyfman A., Long B. High risk and low prevalence diseases: tubo-ovarian abscess. The American Journal of Emergency Medicine. 2022;57:70–75. https://doi.org/10.1016/j.ajem.2022.04.026.

12. Munrós J., Vergara A., Bataller E., et.al. Performance of a rapid molecular test to detect Chlamydia trachomatis and Neisseria gonorrhoeae in women with pelvic inflammatory disease. Enfermedades Infecciosas y Microbiología Clínica (English Edition). 2022;40(7):377–380. https://doi.org/10.1016/j.eimce.2021.03.008.

13. Kreisel K.M., Llata E., Haderxhanaj L., et.al. The Burden of and Trends in Pelvic Inflammatory Disease in the United States, 2006-2016. The Journal of Infectectious Diseases. 2021;224(12):103–112.https://doi.org/10.1093/infdis/jiaa771.

14. Savaris R.F., Fuhrich D.G., Duarte R.V., et.al. Antibiotic therapy for pelvic inflammatory disease. Cochrane Database of Systematic Reviews. 2020;(8):CD010071. https://doi.org/10.1002/14651858.CD010071.pub3.

15.


Review

For citations:


Bogdanova A.M., Knysh O.E., Knysh E.V., Urakov A.V., Mamin E.L. Pelvic inflammatory disease: clinical aspects and influence on women’s reproductive health. Vestnik of North-Eastern Federal University. Medical Sciences. 2026;42(1):5-15. (In Russ.) https://doi.org/10.25587/2587-5590-2026-1-5-15

Views: 111

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2587-5590 (Online)